It was barely two decades earlier that a state more known for manufacturing and as the world’s insurance capital, became host to a handful of fledgling bioscience firms — seven, to be exact — that managed, through good science, good timing, and generous financial backing from the state, to establish Connecticut as a budding hub of bioscience innovation and entrepreneurism.

Achillion, Alexion, CuraGen, Genaissance, Neurogen, Rib-X and Vion. All but Neurogen and Vion still exist, in one form or another and in the memories of those who worked there.